Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by Columbia University
Information provided by (Responsible Party):
Diane George, MD, Columbia University Identifier:
First received: October 17, 2013
Last updated: March 10, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)